Publication:
Paclitaxel (P) (day 1 and 8) and carboplatin (C) given on every 3 weeks in advanced (stage III-IV) non-small cell lung cancer (NSCLC).

Simple item page
dc.contributor.authorsYumuk, PF; Turhal, NS; Gumus, M; Hatabay, NF; Turken, O; Ozkan, A; Salepci, T; Aliustaoglu, M; Ekenel, M; Ahiskali, R
dc.date.accessioned2022-03-12T15:58:59Z
dc.date.accessioned2026-01-11T17:14:49Z
dc.date.available2022-03-12T15:58:59Z
dc.date.issued2004
dc.identifier.doidoiWOS:000223512402763
dc.identifier.issn0732-183X
dc.identifier.urihttps://hdl.handle.net/11424/224242
dc.identifier.wosWOS:000223512402763
dc.language.isoeng
dc.publisherAMER SOC CLINICAL ONCOLOGY
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titlePaclitaxel (P) (day 1 and 8) and carboplatin (C) given on every 3 weeks in advanced (stage III-IV) non-small cell lung cancer (NSCLC).
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage696S
oaire.citation.issue14
oaire.citation.startPage696S
oaire.citation.titleJOURNAL OF CLINICAL ONCOLOGY
oaire.citation.volume22

Files

Collections

Araştırma Çıktıları